Iradimed (IRMD) Free Cash Flow (2013 - 2026)

Iradimed (IRMD) has 14 years of Free Cash Flow data on file, last reported at $7.9 million in Q1 2026.

• On a quarterly basis, Free Cash Flow rose 1225.55% year-over-year to $7.9 million in Q1 2026; TTM through Mar 2026 was $24.5 million, a 68.33% increase from a year earlier, with the FY2025 full-year figure at $17.2 million, down 2.48% from the prior year.
• Free Cash Flow for Q1 2026 stood at $7.9 million, up from $5.6 million in the prior quarter.
• Over the last five years, Free Cash Flow for IRMD reached as high as $10.3 million in Q4 2023 and fell as low as -$2.9 million in Q2 2023.
• Historically, Free Cash Flow has averaged $3.8 million across 5 years, with a median of $3.7 million in 2022.
• Across the five-year window, Free Cash Flow sank 301.68% in 2023 and jumped 1225.55% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at $2.8 million in 2022, then jumped by 268.77% to $10.3 million in 2023, then slumped by 68.83% to $3.2 million in 2024, then soared by 76.08% to $5.6 million in 2025, then jumped by 40.13% to $7.9 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $7.9 million in Q1 2026, $5.6 million in Q4 2025, and $5.8 million in Q3 2025.